Most Read News

The company said that ₹592.26 Crore will be paid in cash, while ₹239.25 Crore will be paid through a share transfer, resulting in a 3.17% holding in Nazara.

However, it is unclear whether the Hyderabad-based company will be Cobenfy's exclusive supplier.

The company's claimed reasons for the split include increased share liquidity, affordability, and a broader investor base.

On the NSE, market breadth shows 1,322 stocks advancing while 1,146 stocks are declining.

The order is for the procurement of materials and installation of a solar power producing plant of 130 MWp/100 MWac.

The sale was formalized through a deed of conveyance on September 26, 2024, encompassing both the land and building associated with the property.

In August, the CDSCO banned more than 156 fixed-dose combination medications from the Indian market.

Earlier this week, Bahadur Dastoor resigned as the company's Chief Financial Officer (CFO), effective September 21.

Recently, RITES announced a bonus share allotment of 1:1 and a final dividend of ₹5 per share for eligible shareholders.

Viyash manufactures active pharmaceutical ingredients (APIs) and drug formulations for the human health segment.